GenEdit is focused on overcoming the major challenge to genetic medicines: Delivery. We aim to overcome this limitation and enable treatment of a broad range of diseases, having a positive impact on the lives of as many people as possible.
The foundation of our company is our NanoGalaxy platform. NanoGalaxy contains a library spanning thousands of unique non-viral, non-lipid, polymer nanoparticles. Using our iterative screening process, we are able to identify polymer nanoparticles that can deliver the needed genetic medicine payload to the needed tissue to treat disease.
We are focusing our research on the treatment of diseases for which our delivery technology can enable therapeutic options that otherwise may not be possible. We are developing an internal pipeline of therapeutic candidates to treat a range of diseases with high unmet medical need.
The foundation of our company is our NanoGalaxy platform. NanoGalaxy contains a library spanning thousands of unique non-viral, non-lipid, polymer nanoparticles. Using our iterative screening process, we are able to identify polymer nanoparticles that can deliver the needed genetic medicine payload to the needed tissue to treat disease.
We are focusing our research on the treatment of diseases for which our delivery technology can enable therapeutic options that otherwise may not be possible. We are developing an internal pipeline of therapeutic candidates to treat a range of diseases with high unmet medical need.
Location: United States, California, South San Francisco
Employees: 11-50
Total raised: $34.5M
Founded date: 2016
Investors 6
| Date | Name | Website |
| - | DCVC | dcvc.com/ |
| - | Korea Inve... | partners.k... |
| - | Sequoia Ca... | sequoiacap... |
| - | Transition... | t1st.vc |
| - | Blue Bear ... | bbv.io/ |
| - | Company K ... | kpartners.... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 23.09.2021 | Series A | $26M | - |
| 11.12.2018 | Seed | $8.5M | - |
Mentions in press and media 8
| Date | Title | Description |
| 27.09.2021 | Digital health news, funding roundup in the prior week; September 27 | UnitedHealthcare makes Apple Fitness available at no cost; Devoted lands $1.2 billion! More healthtech companies are going public, but are they measuring up? A number of 2021 healthtech companies are trading below their IPO price, with redu... |
| 24.09.2021 | Daily funding roundup - September 24, 2021 | Devoted Health raised up to $1.2 billion; Xpansiv landed $100M; GeneEdit secured $26M Devoted Health: Devoted Health is a Waltham, Ma.-based health insurer focused on Medicare Advantage plans. Devoted Health is raising up to $1.2 bil... |
| 23.09.2021 | Aiming for better genetic medicines delivery, startup GenEdit grabs $26M | Adeno-associated virus is a workhorse of genetic medicine, serving as the delivery vehicle for a slew of approved and experimental therapies. But adverse effects are a known risk of AAV; injuries and even patient deaths in clinical trials h... |
| 07.06.2019 | A peek inside Sequoia Capital’s low-flying, wide-reaching scout program | Ten years ago, Sequoia Capital began quietly encouraging founders of its portfolio companies to consider which of their founder friends they might like to get behind financially. Sequoia would let them write checks to those companies, and i... |
| 12.12.2018 | Term Sheet — Wednesday, December 12 | A YEAR OF MEGA-DEALS Good morning, Term Sheet readers. Paid Content Securing the enterprise without boundaries From ExtraHop “Through a fog of uncertainty, IPO markets around the world found a clear path forward and investment opportunities... |
| 11.12.2018 | GenEdit Closes $8.5M Seed Financing | GenEdit, Inc., a Berkeley, CA-based developer of novel polymer nanoparticle technology platform for non-viral-based delivery of gene therapeutics, completed an $8.5m seed financing. The round was led by new investors Data Collective Bio and... |
| 07.12.2018 | Daily funding roundup - December 7th, 2018 | Akumina raised $7.5M; Trustology raised $8M; XyloCor Therapeutics raised $17M; EdCast raised $33.6M OnSiteIQ: OnSiteIQ is a tech-enabled construction visual documentation and Risk Assessment service. OnSiteIQ has raised $2 million in seed f... |
| - | GenEdit | “Developing innovative therapies through targeted delivery of genetic medicines.” |